Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-11-001324
Filing Date
2011-05-11
Accepted
2011-05-11 17:09:36
Documents
5
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk1109843.htm 10-Q 1421864
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10139
3 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 10506
4 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 5914
5 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 5940
  Complete submission text file 0001178913-11-001324.txt   1455629
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 11832741
SIC: 2836 Biological Products, (No Diagnostic Substances)